Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, et al. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA. 2022;327:248–63.

Article  PubMed  Google Scholar 

Jobe AH. Pulmonary surfactant therapy. N. Engl J Med. 1993;328:861–8.

Article  CAS  PubMed  Google Scholar 

Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane database Syst Rev. 2010;2010:Cd001079.

PubMed  PubMed Central  Google Scholar 

Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2000;2:Cd001079.

Google Scholar 

Vitali F, Galletti S, Aceti A, Aquilano G, Fabi M, Balducci A, et al. Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome. Ital J Pediatrics. 2014;40:26.

Article  Google Scholar 

Sobel DB, Carroll A. Postsurfactant slump: early prediction of neonatal chronic lung disease? J Perinatol. 1994;14:268–74.

CAS  PubMed  Google Scholar 

Katz L, Klein J. Repeat surfactant therapy for postsurfactant slump. J Perinatol. 2006;26:414–22.

Article  CAS  PubMed  Google Scholar 

Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, et al. Randomized trial of late surfactant treatment in ventilated preterm infants receiving inhaled nitric oxide. J Pediatrics. 2016;168:23–29.e24.

Article  CAS  Google Scholar 

Hascoët J-M, Picaud J-C, Ligi I, Blanc T, Moreau F, Pinturier M-F, et al. Late surfactant administration in very preterm neonates with prolonged respiratory distress and pulmonary outcome at 1 year of age: a randomized clinical trial. JAMA Pediatrics. 2016;170:365–72.

Article  PubMed  Google Scholar 

McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child-Fetal Neonatal Ed. 2007;92:F424–F427.

Article  PubMed  PubMed Central  Google Scholar 

Sehgal A, Mak W, Dunn M, Kelly E, Whyte H, McCrindle B, et al. Haemodynamic changes after delivery room surfactant administration to very low birth weight infants. Arch Dis Child-Fetal Neonatal Ed. 2010;95:F345–F351.

Article  PubMed  Google Scholar 

Sehgal A, Bhatia R, Roberts CT. Cardiorespiratory Physiology following Minimally Invasive Surfactant Therapy in Preterm Infants. Neonatology. 2019;116:278–85.

Article  CAS  PubMed  Google Scholar 

Jung YH, Jang J, Kim HS, Shin SH, Choi CW, Kim EK, et al. Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants. BMC Pediatr. 2019;19:121.

Article  PubMed  PubMed Central  Google Scholar 

Mertens L, Seri I, Marek J, Arlettaz R, Barker P, McNamara P, et al. Targeted Neonatal Echocardiography in the Neonatal Intensive Care Unit: practice guidelines and recommendations for training. Writing Group of the American Society of Echocardiography (ASE) in collaboration with the European Association of Echocardiography (EAE) and the Association for European Pediatric Cardiologists (AEPC). J Am Soc Echocardiogr. 2011;24:1057–78.

Article  PubMed  Google Scholar 

Bischoff AR, Giesinger RE, Rios DR, Mertens L, Ashwath R, McNamara PJ. Anatomic Concordance of Neonatologist-Performed Echocardiography as Part of Hemodynamics Consultation and Pediatric Cardiology. J Am Soc Echocardiogr. 2021;34:301–7.

Article  PubMed  Google Scholar 

Rios DR, Martins FF, El-Khuffash A, Weisz DE, Giesinger RE, McNamara PJ. Early Role of the Atrial-Level Communication in Premature Infants with Patent Ductus Arteriosus. J Am Soc Echocardiogr. 2021;34:423–32.e421.

Article  PubMed  Google Scholar 

Sindelar R, Nakanishi H, Stanford AH, Colaizy TT, Klein JM. Respiratory management for extremely premature infants born at 22 to 23 weeks of gestation in proactive centers in Sweden, Japan, and USA. Semin Perinatol. 2021;46:151540 https://doi.org/10.1016/j.semperi.2021.151540.

Merrill JD, Ballard RA, Cnaan A, Hibbs AM, Godinez RI, Godinez MH, et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res. 2004;56:918–26.

Article  CAS  PubMed  Google Scholar 

Deshpande P, Baczynski M, McNamara PJ, Jain A. Patent ductus arteriosus: The physiology of transition. Semin Fetal Neonatal Med. 2018;23:225–231.

Haworth SG. Pulmonary endothelium in the perinatal period. Pharmacol Rep. 2006;58:153.

PubMed  Google Scholar 

Davis P, Turner-Gomes S, Cunningham K, Way C, Roberts R, Schmidt B. Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus. Arch Pediatrics Adolesc Med. 1995;149:1136–41.

Article  CAS  Google Scholar 

Kindler A, Seipolt B, Heilmann A, Range U, Rüdiger M, Hofmann SR. Development of a diagnostic clinical score for hemodynamically significant patent ductus arteriosus. Front Pediatrics. 2017;5:280.

Article  Google Scholar 

de Boode W, Kluckow M, McNamara P, Gupta S. Role of neonatologist-performed echocardiography in the assessment and management of patent ductus arteriosus physiology in the newborn. Semin Fetal Neonatal Med. 2018;23:292–297.

Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatrics Child Health. 1994;30:406–11.

Article  CAS  Google Scholar 

Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Therapeutics. 2007;12:138–46.

Article  Google Scholar